Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
000733.SZ Stock Summary
Top 10 Correlated ETFs
000733.SZ
In the News
000733.SZ Financial details
Company Rating
Buy
Market Cap
30.88B
Income
2.58B
Revenue
7.6B
Book val./share
25.86
Cash/share
6.46
Dividend
1.15
Dividend %
2.27%
Employees
7.28K
Optionable
No
Shortable
Yes
Earnings
27 Apr 2024
P/E
10.42
Forward P/E
7.15
PEG
1.48
P/S
3.8
P/B
1.95
P/C
8.29
P/FCF
23.18
Quick Ratio
4.21
Current Ratio
5.29
Debt / Equity
0.11
LT Debt / Equity
0.06
-
-
EPS (TTM)
4.93
EPS next Y
7.49
EPS next Q
-
EPS this Y
59.17%
EPS next Y
51.93%
EPS next 5Y
51.93%
EPS last 5Y
52.93%
Revenue last 5Y
6.37%
Revenue Q/Q
-22.29%
EPS Q/Q
-35.29%
-
-
-
-
SMA20
5.12%
SMA50
4.75%
SMA100
-14.86%
Inst Own
-
Inst Trans
-
ROA
14%
ROE
23%
ROC
0.19%
Gross Margin
62%
Oper. Margin
39%
Profit Margin
34%
Payout
25%
Shs Outstand
554.17M
Shs Float
358.7M
-
-
-
-
Target Price
-
52W Range
40.36-98.7
52W High
-45.36%
52W Low
+33.88%
RSI
46.56
Rel Volume
0.53
Avg Volume
12.59M
Volume
6.62M
Perf Week
-8.84%
Perf Month
13.69%
Perf Quarter
-
Perf Half Y
-32.08%
-
-
-
-
Beta
0.518
-
-
Volatility
1.84%, 4.11%
Prev Close
-1.91%
Price
53.55
Change
4.59%
000733.SZ Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 11.28 | 7.13 | 7.67 | 10.98 | 14.02 | |
Net income per share | 0.55 | 0.58 | 1.18 | 2.89 | 4.6 | |
Operating cash flow per share | 0.67 | 0.5 | -0.13 | 2.59 | 1.58 | |
Free cash flow per share | 0.13 | -0.14 | -0.91 | 1.67 | 0.74 | |
Cash per share | 2.11 | 1.73 | 0.35 | 1.74 | 2.32 | |
Book value per share | 10.19 | 10.45 | 11.6 | 14.45 | 18.82 | |
Tangible book value per share | 10.05 | 10.08 | 11.26 | 14.12 | 18.51 | |
Share holders equity per share | 10.19 | 10.45 | 11.6 | 14.45 | 18.82 | |
Interest debt per share | 5.56 | 3.38 | 2.92 | 2.54 | 2.5 | |
Market cap | 5.21B | 8.83B | 30.3B | 64.01B | 59.21B | |
Enterprise value | 6.44B | 9.16B | 30.82B | 63.62B | 58.65B | |
P/E ratio | 20.13 | 29.67 | 50.03 | 42.94 | 24.85 | |
Price to sales ratio | 0.98 | 2.41 | 7.67 | 11.32 | 8.15 | |
POCF ratio | 16.38 | 34.02 | -437.56 | 47.94 | 72.09 | |
PFCF ratio | 86.83 | -125.18 | -64.53 | 74.54 | 154.57 | |
P/B Ratio | 1.08 | 1.64 | 5.07 | 8.6 | 6.07 | |
PTB ratio | 1.08 | 1.64 | 5.07 | 8.6 | 6.07 | |
EV to sales | 1.21 | 2.5 | 7.8 | 11.25 | 8.07 | |
Enterprise value over EBITDA | 8.92 | 10.95 | 23.71 | 29.53 | 17.98 | |
EV to operating cash flow | 20.25 | 35.3 | -445.19 | 47.65 | 71.42 | |
EV to free cash flow | 107.34 | -129.89 | -65.65 | 74.09 | 153.12 | |
Earnings yield | 0.05 | 0.03 | 0.02 | 0.02 | 0.04 | |
Free cash flow yield | 0.01 | -0.01 | -0.02 | 0.01 | 0.01 | |
Debt to equity | 0.53 | 0.31 | 0.24 | 0.17 | 0.13 | |
Debt to assets | 0.25 | 0.19 | 0.16 | 0.11 | 0.09 | |
Net debt to EBITDA | 1.7 | 0.4 | 0.41 | -0.18 | -0.17 | |
Current ratio | 1.94 | 3.05 | 2.87 | 2.96 | 4.15 | |
Interest coverage | 3.88 | 9.98 | 20.01 | 35.82 | 69.16 | |
Income quality | 1.24 | 0.88 | -0.11 | 0.89 | 0.34 | |
Dividend Yield | 0.02 | 0.01 | 0 | 0 | 0 | |
Payout ratio | 0.32 | 0.31 | 0.13 | 0.08 | 0.08 | |
Sales general and administrative to revenue | 0.02 | 0.03 | 0.03 | 0.02 | 0.02 | |
Research and developement to revenue | 0.04 | 0.06 | 0.08 | 0.07 | 0.07 | |
Intangibles to total assets | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | |
Capex to operating cash flow | -0.81 | -1.27 | 5.78 | -0.36 | -0.53 | |
Capex to revenue | -0.05 | -0.09 | -0.1 | -0.08 | -0.06 | |
Capex to depreciation | -1.15 | -1.91 | -2.07 | -2.09 | -1.63 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 11.2 | 11.66 | 17.52 | 30.67 | 44.12 | |
ROIC | 0.04 | 0.07 | 0.12 | 0.17 | 0.21 | |
Return on tangible assets | 0.03 | 0.03 | 0.07 | 0.14 | 0.18 | |
Graham Net | -0.65 | 0.91 | 1.21 | 2.78 | 5.68 | |
Working capital | 3.6B | 4.05B | 3.92B | 5.28B | 7.58B | |
Tangible asset value | 4.76B | 5.19B | 5.8B | 7.27B | 9.6B | |
Net current asset value | 2.28B | 2.65B | 3.04B | 4.29B | 6.18B | |
Invested capital | 0.53 | 0.31 | 0.24 | 0.17 | 0.13 | |
Average receivables | 4.12B | 3.76B | 3.58B | 4.12B | 5.13B | |
Average payables | 1.87B | 1.18B | 809.53M | 1.14B | 1.5B | |
Average inventory | 1.37B | 1.18B | 1.02B | 1.47B | 2.07B | |
Days sales outstanding | 287.46 | 329.87 | 355.3 | 283.82 | 294.94 | |
Days payables outstanding | 153.47 | 123.01 | 185.39 | 220.74 | 222.46 | |
Days of inventory on hand | 129.44 | 169.72 | 218.31 | 304.04 | 308.35 | |
Receivables turnover | 1.27 | 1.11 | 1.03 | 1.29 | 1.24 | |
Payables turnover | 2.38 | 2.97 | 1.97 | 1.65 | 1.64 | |
Inventory turnover | 2.82 | 2.15 | 1.67 | 1.2 | 1.18 | |
ROE | 0.05 | 0.06 | 0.1 | 0.2 | 0.24 | |
Capex per share | -0.55 | -0.64 | -0.78 | -0.93 | -0.85 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 3.6 | 3.02 | 4.04 | 4.25 | 3.23 | |
Net income per share | 1.14 | 1 | 1.41 | 1.53 | 0.99 | |
Operating cash flow per share | 1.14 | 1 | 1.41 | 0.99 | -0.21 | |
Free cash flow per share | 0.94 | 0.81 | 1.29 | 0.82 | -0.51 | |
Cash per share | 1.26 | 2.32 | 2.35 | 2.3 | 6.46 | |
Book value per share | 17.67 | 18.82 | 20.16 | 20.54 | 25.86 | |
Tangible book value per share | 17.38 | 18.51 | 19.86 | 20.25 | 25.58 | |
Share holders equity per share | 17.67 | 18.82 | 20.16 | 20.54 | 25.86 | |
Interest debt per share | 2.1 | 2.45 | 2.58 | 2.94 | 2.77 | |
Market cap | 60.09B | 59.21B | 46.87B | 49.88B | 43B | |
Enterprise value | 59.88B | 58.65B | 46.37B | 49.51B | 40.35B | |
P/E ratio | 25.43 | 28.53 | 15.95 | 15.67 | 20.35 | |
Price to sales ratio | 32.22 | 37.8 | 22.3 | 22.57 | 25.04 | |
POCF ratio | 101.73 | 114.11 | 63.8 | 96.43 | -385.33 | |
PFCF ratio | 123.58 | 141.06 | 70.02 | 117.22 | -158.87 | |
P/B Ratio | 6.56 | 6.07 | 4.47 | 4.67 | 3.13 | |
PTB ratio | 6.56 | 6.07 | 4.47 | 4.67 | 3.13 | |
EV to sales | 32.11 | 37.45 | 22.06 | 22.41 | 23.5 | |
Enterprise value over EBITDA | 82.35 | 95.23 | 48.92 | 49.16 | 62.58 | |
EV to operating cash flow | 101.38 | 113.04 | 63.12 | 95.72 | -361.57 | |
EV to free cash flow | 123.15 | 139.74 | 69.28 | 116.35 | -149.07 | |
Earnings yield | 0.01 | 0.01 | 0.02 | 0.02 | 0.01 | |
Free cash flow yield | 0.01 | 0.01 | 0.01 | 0.01 | -0.01 | |
Debt to equity | 0.12 | 0.13 | 0.13 | 0.14 | 0.11 | |
Debt to assets | 0.08 | 0.09 | 0.09 | 0.1 | 0.08 | |
Net debt to EBITDA | -0.28 | -0.9 | -0.52 | -0.37 | -4.11 | |
Current ratio | 3.33 | 4.15 | 4.19 | 4.1 | 5.29 | |
Interest coverage | 77.43 | 53.59 | 81.91 | 81.58 | 52.72 | |
Income quality | 1 | 1 | 1 | 0.65 | -0.21 | |
Dividend Yield | 0 | 0 | 0 | 0.01 | 0 | |
Payout ratio | 0.27 | 0.01 | 0.01 | 0.76 | 0.02 | |
Sales general and administrative to revenue | 0.28 | -0.29 | 0.09 | -0.06 | 0.28 | |
Research and developement to revenue | 0.07 | 0.1 | 0.06 | 0.05 | 0.07 | |
Intangibles to total assets | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Capex to operating cash flow | -0.18 | -0.19 | -0.09 | -0.18 | 1.43 | |
Capex to revenue | -0.06 | -0.06 | -0.03 | -0.04 | -0.09 | |
Capex to depreciation | -1.29 | -1.22 | -0.79 | -1.11 | 1.16 | |
Stock based compensation to revenue | 0 | 0.01 | 0 | 0 | 0 | |
Graham number | 21.29 | 20.59 | 25.31 | 26.58 | 24.06 | |
ROIC | 0.06 | 0.05 | 0.06 | 0.06 | 0.03 | |
Return on tangible assets | 0.04 | 0.04 | 0.05 | 0.05 | 0.03 | |
Graham Net | 4.67 | 5.68 | 6.56 | 6.6 | 11.82 | |
Working capital | 7.02B | 7.58B | 8.4B | 8.55B | 11.46B | |
Tangible asset value | 9.01B | 9.6B | 10.34B | 10.54B | 13.58B | |
Net current asset value | 5.81B | 6.18B | 6.91B | 7.03B | 10.02B | |
Invested capital | 0.12 | 0.13 | 0.13 | 0.14 | 0.11 | |
Average receivables | 6.13B | 6.19B | 6.39B | 7.06B | 7.52B | |
Average payables | 1.73B | 1.71B | 1.66B | 1.64B | 1.62B | |
Average inventory | 2.15B | 2.25B | 2.29B | 2.24B | 2.18B | |
Days sales outstanding | 314.31 | 337.43 | 295.35 | 294.35 | 409.44 | |
Days payables outstanding | 225.3 | 269.75 | 195.12 | 171.52 | 194.04 | |
Days of inventory on hand | 281.01 | 373.89 | 269.91 | 230.43 | 264 | |
Receivables turnover | 0.29 | 0.27 | 0.3 | 0.31 | 0.22 | |
Payables turnover | 0.4 | 0.33 | 0.46 | 0.52 | 0.46 | |
Inventory turnover | 0.32 | 0.24 | 0.33 | 0.39 | 0.34 | |
ROE | 0.06 | 0.05 | 0.07 | 0.07 | 0.04 | |
Capex per share | -0.2 | -0.19 | -0.13 | -0.18 | -0.3 |
000733.SZ Frequently Asked Questions
What is China Zhenhua (Group) Science & Technology Co., Ltd stock symbol ?
China Zhenhua (Group) Science & Technology Co., Ltd is a CN stock and trading under the symbol 000733.SZ
What is China Zhenhua (Group) Science & Technology Co., Ltd stock quote today ?
China Zhenhua (Group) Science & Technology Co., Ltd stock price is $53.55 today.
Is China Zhenhua (Group) Science & Technology Co., Ltd stock public?
Yes, China Zhenhua (Group) Science & Technology Co., Ltd is a publicly traded company.